Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Psychedelics Not all Oregon cities approve of the state’s magic mushroom laws Four of them voted to implement new bans on usage of the psychedelic compound in the Nov. 5 election Rowan DunneNovember 22, 2024
Cannabis FDA gives long-awaited green light to veterans cannabis trial for PTSD After 3 years of negotiating, a cannabis smoking study with 320 American vets is about to kick off Rowan DunneNovember 20, 2024
Psychedelics Can psychedelics help with chronic pain? Research shows that substances like Psychedelics like LSD, DMT and magic mushrooms can be used in medicine Adeline EeMay 24, 2024
Psychedelics Portland VA opens psychedelic therapy clinic for mental health and substance use disorders Two clinical trials are under way at the Social Neuroscience & Psychotherapy Lab Rowan DunneApril 2, 2024
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Legalization Georgia advances bill to create psychedelic study group focused on Veterans’ mental health Lawmakers note that current therapeutic trials for substance use issues exclude people with a history of substance abuse Natalia Buendia CalvilloMarch 29, 2022
International Australian researchers granted $3M for psychedelic mental health treatments Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa Nick LabaJanuary 17, 2022
Canada Annual medical cannabis reimbursements for Canadian veterans rise 40% to $119M According to Veterans Affairs Canada, a record number of nearly 16,000 clients were paid back for medical weed Kathryn TindaleJune 7, 2021